UBS O'Connor’s CDK Global, Inc. CDK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,289,369
Closed -$290M 1082
2022
Q2
$290M Buy
+5,289,369
New +$286M 3.01% 6
2020
Q1
Sell
-80,000
Closed -$4.37M 418
2019
Q4
$4.37M Sell
80,000
-90,000
-53% -$4.62M 0.12% 142
2019
Q3
$8.18M Sell
170,000
-80,000
-32% -$3.83M 0.23% 84
2019
Q2
$12.4M Buy
+250,000
New +$13.4M 0.24% 59
2019
Q1
Sell
-350,000
Closed -$16.8M 175
2018
Q4
$16.8M Sell
350,000
-50,000
-13% -$2.64M 0.6% 43
2018
Q3
$25M Hold
400,000
0.57% 41
2018
Q2
$26M Buy
400,000
+80,000
+25% +$5.17M 0.52% 39
2018
Q1
$20.3M Buy
320,000
+20,000
+7% +$1.4M 0.39% 36
2017
Q4
$21.4M Sell
300,000
-220,000
-42% -$14.8M 0.38% 57
2017
Q3
$32.8M Buy
520,000
+40,000
+8% +$2.52M 0.48% 44
2017
Q2
$29.8M Buy
480,000
+155,000
+48% +$9.72M 0.49% 48
2017
Q1
$21.1M Buy
325,000
+29,918
+10% +$1.92M 0.36% 69
2016
Q4
$17.6M Sell
295,082
-145,979
-33% -$8.35M 0.34% 85
2016
Q3
$25.3M Sell
441,061
-44,647
-9% -$2.57M 0.38% 59
2016
Q2
$27M Sell
485,708
-30,282
-6% -$1.56M 0.58% 43
2016
Q1
$24M Sell
515,990
-11,201
-2% -$499K 0.44% 63
2015
Q4
$25M Buy
527,191
+140,924
+36% +$6.84M 0.42% 54
2015
Q3
$18.5M Buy
386,267
+162,752
+73% +$8.26M 0.38% 72
2015
Q2
$12.1M Sell
223,515
-31,393
-12% -$1.61M 0.21% 133
2015
Q1
$11.9M Buy
254,908
+8,248
+3% +$376K 0.26% 118
2014
Q4
$10.1M Buy
+246,660
New +$8.74M 0.17% 147

Other funds holding CDK

UBS O'Connor's CDK Position: Q3 2022 in Review

UBS O'Connor sold out of CDK Global, Inc. (CDK) in Q3 2022, closing a stake of 5,289,369 shares — an estimated $290M sold.

UBS O'Connor first reported a position in CDK in Q4 2014 and held it in 21 quarters. The position peaked at $290M in Q2 2022. 6 funds tracked by Wall St. Rank hold CDK as of Q3 2022.

  • UBS O'Connor reported no remaining CDK Global, Inc. position as of Q3 2022 after selling out during the quarter.
  • UBS O'Connor sold 5,289,369 CDK Global, Inc. shares in Q3 2022, an estimated $290M.
  • UBS O'Connor first reported a position in CDK Global, Inc. in Q4 2014 and held it in 21 quarters.
  • UBS O'Connor's CDK Global, Inc. position peaked at $290M in Q2 2022.
  • 6 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q3 2022.

Based on UBS O'Connor's 13F filing for Q3 2022, filed 14 Nov 2022.